Market Authorization Processes is a regulatory evaluation framework within pharmaceutical governance that distinguishes itself by systematically assessing the safety, efficacy, and quality of medical products to determine their eligibility for commercial distribution and public use.
313
Publications
12.3K
Citations
1K
Authors
550
Institutions
Publications per year
2017–2026
120
Variants
Marketing Authorization Processes
Parents
Publications
313
1–5 of 313
Authors
1K
- SWStuart Walker
Centre for Innovation in Regulatory Science, United Kingdom
10 publications · 177 citations
10
h-index
- JS
9
h-index
- SS
8
h-index
- HG
6
h-index
- SGSilvio Garattini
Mario Negri Institute for Pharmacological Research, Italy
6 publications · 296 citations
6
h-index
1–5 of 1K
Institutions
550
Utrecht University
Utrecht, The Netherlands
16 h-index
43 publications
1.8K citations
Centre for Innovation in Regulatory Science
London, United Kingdom
12 h-index
27 publications
503 citations
European Medicines Agency
Amsterdam, Netherlands
10 h-index
34 publications
2.1K citations
United States Food and Drug Administration
Silver Spring, United States
10 h-index
17 publications
1.8K citations
London School of Economics and Political Science
London, United Kingdom
9 h-index
24 publications
507 citations
Yale University
New Haven, United States
9 h-index
22 publications
1.8K citations
University of Hertfordshire
Hatfield, United Kingdom
8 h-index
21 publications
315 citations
Harvard University
Cambridge, United States
8 h-index
16 publications
439 citations
1–8 of 550
Venues
- PubMed
Repository · 13 publications · 684 citations
11
h-index
- Clinical Pharmacology & Therapeutics
CPT · 10 publications · 458 citations
10
h-index
- Frontiers in Pharmacology
10 publications · 338 citations
10
h-index
- BMJ
8 publications · 126 citations
8
h-index
- New England Journal of Medicine
NEJM · 8 publications · 571 citations
8
h-index
1–5